AI-generated summary
The authors studied 100 adults with peptic or duodenal ulcer exacerbation, comparing 75 patients given drug plus low-intensity laser therapy with 25 given drug therapy alone. They report an immunocorrective effect of the laser methods during exacerbation and a larger decrease in Helicobacter pylori contamination in the laser group.
- Participants
- 100
- Who or what was studied
- Adults aged 18 to 65 with exacerbation of peptic or duodenal ulcer
- Limits stated in the abstract
- The abstract does not report wavelengths, laser parameters, randomization, or statistical significance, and the control group is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on pubmed.ncbi.nlm.nih.gov.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.